{"id":2874,"date":"2017-08-25T08:15:56","date_gmt":"2017-08-25T12:15:56","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=2874"},"modified":"2017-08-25T08:18:50","modified_gmt":"2017-08-25T12:18:50","slug":"ipo-pipeline-update-another-quiet-week-on-the-filing-front","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-another-quiet-week-on-the-filing-front\/","title":{"rendered":"IPO Pipeline Update: Another quiet week on the filing front"},"content":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 54 active IPOs in the pipeline as of August 25, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why &#8220;looks may be perceiving&#8221; when it comes to the IPO pipeline<a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=2877\" target=\"_blank\"><strong> in this article.<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/08\/Screen-Shot-2017-08-25-at-8.14.13-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-2875\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/08\/Screen-Shot-2017-08-25-at-8.14.13-AM.png\" alt=\"Screen Shot 2017-08-25 at 8.14.13 AM\" width=\"650\" height=\"399\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/08\/Screen-Shot-2017-08-25-at-8.14.13-AM.png 650w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/08\/Screen-Shot-2017-08-25-at-8.14.13-AM-600x368.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/08\/Screen-Shot-2017-08-25-at-8.14.13-AM-300x184.png 300w\" sizes=\"(max-width: 650px) 100vw, 650px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"text-decoration: underline;\">NEW FILINGS<\/span><\/p>\n<p>Company: <strong>Krystal Biotech, Inc.<\/strong><br \/>\nSymbol: KRYS<br \/>\nDescription: They are a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Ladenburg Thalmann<br \/>\nFiled: 8-21-17<br \/>\nListed Cash Raise: $34.5 million<\/p>\n<p>Company: <strong>Celcuity LLC<\/strong><br \/>\nSymbol: CELC<br \/>\nDescription: They are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Craig Hallum Capital Group<br \/>\nFiled: 8-23-17<br \/>\nListed Cash Raise: $15 million<\/p>\n<p><span style=\"text-decoration: underline;\">UPDATED TERMS<\/span><\/p>\n<p>(none to report)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 54 active IPOs in the pipeline as of August 25, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why &#8220;looks may be perceiving&#8221; when it comes to the IPO pipeline in this article. &nbsp; NEW FILINGS[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[1329,1330],"class_list":["post-2874","post","type-post","status-publish","format-standard","hentry","category-ipo","tag-celc","tag-krys"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=2874"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2874\/revisions"}],"predecessor-version":[{"id":2880,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2874\/revisions\/2880"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=2874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=2874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=2874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}